Phase 2 Hepatocellular Carcinoma Non-resectable Clinical Trials
12 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–12 of 12 trials
Recruiting
Phase 2
Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma Non-resectable
Chang Gung Memorial Hospital45 enrolled1 locationNCT06133062
Recruiting
Phase 2
Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC
Hepatocellular Carcinoma Non-resectableHCC
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest55 enrolled12 locationsNCT04522544
Recruiting
Phase 2
Lenvatinib Plus SIRT vs Lenvatinib in TACE-Refractory HCC
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University78 enrolled1 locationNCT06904196
Recruiting
Phase 2
Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma
Hepatocellular Carcinoma Non-resectable
Queen's Medical Center80 enrolled1 locationNCT04965454
Recruiting
Phase 2
Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University320 enrolled1 locationNCT06904183
Recruiting
Phase 2
Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion
Liver CancerHepatocellular CarcinomaHepatocellular Cancer+2 more
Asan Medical Center138 enrolled1 locationNCT05992220
Recruiting
Phase 2
DEB-TACE+RALOX-HAIC vs DEB-TACE for Large HCC
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University130 enrolled1 locationNCT06397235
Recruiting
Phase 2
Combined HAIC, Lenvatinib and Cadonilimab As Conversion Therapy for Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma Non-resectable
Tongji Hospital36 enrolled1 locationNCT06187961
Recruiting
Phase 2
mFOLFOX7 Plus Camrelizumab and Apatinib in BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan Criteria
Hepatocellular Carcinoma Non-resectable
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University29 enrolled1 locationNCT06607107
Recruiting
Phase 2
Atezolizumab/Bevacizumab Followed by On-demand TACE or Initial Synchronous Treatment With TACE and Atezolizumab/Bevacizumab
Hepatocellular Carcinoma Non-resectable
Ludwig-Maximilians - University of Munich106 enrolled7 locationsNCT04224636
Recruiting
Phase 2
Sintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCC
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University23 enrolled1 locationNCT06397222
Recruiting
Phase 2
Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）.
Hepatocellular CarcinomaHepatocellular Carcinoma Non-resectable
Tianjin Medical University Cancer Institute and Hospital30 enrolled1 locationNCT06375486